Development of Sample Clauses

Development of. Merck shall pay to GTx upon first achievement of the following milestones by [ * ]. [ * ]
AutoNDA by SimpleDocs
Development of. Praxis will have the right (but not the obligation) at any time after Praxis exercises the Option under Section 5.1 until [***], to [***] the [***]. If Praxis seeks to [***] the [***], then Praxis will notify Ionis and such [***]. If the Parties mutually agree that Praxis may [***] the [***], then the Parties will, as soon as practicable but no later than [***] after agreeing to such [***], negotiate an appropriate amendment of this Agreement. Prior to Praxis’ initiation of any [***], Praxis will notify Ionis of [***] provide the JSC with drafts of [***] (“[***]”) and a [***] (“[***]”) for such [***]. The contents of the [***] and the [***] will be similar to the contents of the [***]. The JSC will be responsible for reviewing and approving the [***] and the [***], and any updates or amendments thereto, proposed by Praxis. If the JSC cannot agree upon any aspect of the [***] or the [***] or any update or amendment thereto, the matter will be referred to the Senior Representatives for resolution. If the Senior Representatives cannot agree on the [***] or the [***] within [***] after the matter is so referred, then Ionis will have final decision-making authority with respect to [***], provided that Ionis’ decision is consistent with the choices Ionis makes for its other similar programs, and Praxis will have final decision-making authority with respect to (a) [***] and (b) [***], in each case except as set forth in Section 4.1.4(b) with respect to matters arising after Praxis’ exercise of the Option. As between the Parties, Praxis will be solely responsible, at its own cost and expense, for [***].
Development of. (i) criteria for the design of watershed management plans aimed to improve regional environmental management capacity and to protect and reclaim coastal watersheds; and (ii) a strategic environmental assessment of the Borrower’s northern coast, including the design of strategies for environmental management, compatible with the long term regional economic development and preservation goals.
Development of. [***] MLCs. (a) 3D Line will perform a development program (the “Program”) directed toward the development of [***] MLCs that meet the Specifications (including the documents referenced therein). The Program will be performed in two iterations with 3D Line delivering to ViewRay: (i) within four (4) months after the Effective Date, complete design plans for the [***] MLCs that are suitable for manufacturing [***] MLCs that conform to the Specifications; (ii) [intentionally omitted]; (iii) within one (1) month after ViewRay makes the payment under Section 2.2(b) “final” design plans for the [***] MLCs that conform to the Specifications that include detailed engineering and fabrication information sufficient to enable commercial scale manufacture; and (iv) within two (2) months after ViewRay makes the payment under Section 2.2(c), but not later than January 15, 2010 unless ViewRay notifies 3D Line that ViewRay is willing to accept a later delivery date, [***] MLCs that conform to the Specifications (each, a “Deliverable”).
Development of a transition plan of care in coordination with the care setting, the enrollee and other key members of an enrollee’s multi-disciplinary team prior to the transition which is provided in writing to the enrollee upon discharge and includes post discharge care appointments and linkages as appropriate, medication reconciliation, patient education and self- management strategies; addresses prior authorization needs; and a contact person and phone number for the enrollee.
Development of. Subject to the advance written agreement on a Statement of Work, the Parties shall work together to develop the [*]. The Parties will use commercially reasonable efforts to scope and negotiate the related Statement of Work within [*] after the Effective Date, and to develop [*]. BBY will also [*]. For the avoidance of doubt, it would be BBY’s intent to [*]. For purposes of clarity, the Parties understand and agree that the [*].
Development of supply of...; etc.) Business and technical discussions and other exchanges of information between the parties related to the supply of products and/or services by Company to JDSU.
AutoNDA by SimpleDocs
Development of. If a Party wishes to Develop [...***...] other than the Existing Product (such as an [...***...]) or to Develop any [...***...] (including the Existing Product) for any indication other than CDI, then it shall propose such Development to the JSC. The Parties, through the JSC, will determine whether (i) to collaborate in the [...***...], subject to agreement to a Development Plan for such [...***...] and agreement that each Party shall be responsible for [...***...] of all Development Expenses incurred by the Parties in the Development of such [...***...] in the Field, or (ii) to proceed with Development of such [...***...] in the Field separately in their respective territories. If the Parties do not agree to collaborate in the global Development of such [...***...], then (A) Optimer shall be free (itself or with any Affiliate or Third Party) to Develop such [...***...] at its own expense, but will conduct such Development activities only outside the Territory to the extent required to comply with Section 2.5(b), and (B) Partner shall be free (itself or with any Affiliate or Third Party) to Develop such [...***...] at its own expense, but will conduct such Development activities only in the Territory. Partner shall not have the right to access or use any Data generated by or on behalf of Optimer with respect such [...***...], and *** Confidential Treatment Requested
Development of. University of Florida will work in conjunction with CVT Chemists to develop [ ]. In particular the [ ] which confers such [ ] therefore [ ]. CVT and University of Florida Scientists will work together [ ]. These [ ] may be the subject of [ ].
Development of. [***] for a Drug Discovery Program. If either Party wishes to Develop a Licensed Product comprising a [***] that is not already set forth in the Drug Discovery Plan for such Drug Discovery Program, then such Party may propose such additional activities to the other Party and the Parties will discuss whether to amend such Drug Discovery Plan or create a separate Drug Discovery Program for such [***]. If the Parties agree to include the additional [***] in the Drug Discovery Program, then the Parties will enter into a mutually acceptable amended Drug Discovery Plan that includes the additional [***]. For clarity, neither Party will have any obligation to agree to amend a Drug Discovery Plan to include any additional [***] that were not set forth in the initial Drug Discovery Plan for the applicable Drug Discovery Program.
Time is Money Join Law Insider Premium to draft better contracts faster.